We chat with BioViva CEO Liz Parrish, who has heroically injected herself with a live virus meant to transfect her with two genes- telomerase and follistatin.
No Responses
Reading Time: < 1 minute
Live Interview: Telomerase gene therapy with Liz Parrish, CEO and Patient Zero


In this light-hearted interview, we chat with BioViva CEO Liz Parrish, who has heroically injected herself with a live virus meant to transfect her with two genes- telomerase and follistatin.

Her personal hope and that of her company is that it will not harm her but lizhulkrather extend her healthy lifespan and allow her to maintain muscle mass despite her age of 45.

Learn about the journey that may lead her to be known as the Marie Curie (or the Dr. Bruce Banner) of our generation.

Will telomerase gene therapy prove to be a cure for aging?  Time will tell.

 

Leave a Comment

Your email address will not be published. Required fields are marked *

How can I help you?

Drop me a line to find out

Contact Us

DISCLAIMER: This website is for educational purposes only and is not for advertising.  Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.

Facebook-f Twitter Youtube

Navigation

Subscribe to Dr. Park's weekly newsletter

Required fields

© 2020 Recharge Biomedical

Exosomes and TA-65 are not FDA-approved to prevent or treat any illness